The latest Liver Imaging Reporting And Data System (LI-RADS v2014) incorporates gadoxetic acid-enhanced MRI into the diagnostic algorithm of hepatocellular carcinoma (HCC). In this study, we investigated the effects of ancillary features of gadoxetic acid-enhanced MRI in the determination of LI-RADS categories of HCCs. On gadoxetic acid-enhanced MRI, LI-RADS showed sensitivities of 69.0% and 67.8% in the diagnosis of HCCs (LR-5/5v) in two reviewers, respectively. Ancillary features of HCCs on gadoxetic acid-enhanced MRI including hepatobiliary imaging features frequently resulted in upgrade LR-3 to LR-4.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords